False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss how to approach the management of patients in clinic when there is concern for a possible false positive on the…
Read the full articleYou might also wanna read
EFL066 - Islet Autoantibodies
For our 66th episode, we review a recent Journal of the Endocrine Society (JES) article that looks at the frequency of positive islet antibo
Nature research paper: Correcting congenital myasthenia-associated acetylcholine receptor defects
Nature research paper: Correcting congenital myasthenia-associated acetylcholine receptor defects
EAN 2026: Positive trial data for cemdisiran underscores potential for use in generalized MG, says GlobalData
On June 30, at the 12th Congress of the European Academy of Neurology (EAN) 2026, Regeneron announced the results from an additional analysi
Anti-nephrin antibodies are not enriched in patients with primary and posttransplant recurrent podocytopathies
BACKGROUND Anti-nephrin autoantibodies have emerged as a putative pathogenic driver in a subset of patients with podocytopathies, including
Nephrin autoimmunity: signal, noise, and a path to clarity
Advances in antigen discovery and autoantibody profiling have reshaped the classification of autoimmune kidney diseases, moving beyond purel
Realizing the potential of agonistic antibody immunotherapy
Agonistic antibodies show promise in immune therapy but have limited patient success. Recent advances could change this. Retweet if interest
Comments
Sign in to join the conversation.
No comments yet. Be the first.